Chargement en cours...

Immune biomarkers of anti-EGFR monoclonal antibody therapy

The tumor antigen (TA)-targeted monoclonal antibodies (mAb) cetuximab and panitumumab target the human epidermal growth factor receptor and have been integrated into treatment regimens for advanced squamous cell carcinoma of the head and neck (SCCHN). The therapeutic efficacy of these mAbs has been...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Oncol
Auteurs principaux: Trivedi, S., Concha-Benavente, F., Srivastava, R. M., Jie, H. B., Gibson, S. P., Schmitt, N. C., Ferris, R. L.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4269339/
https://ncbi.nlm.nih.gov/pubmed/24997207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdu156
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!